documents: FDA-1995-S-0039-0321

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1995-S-0039-0321 FDA FDA-1995-S-0039 Attachment 1 - Shah, et al., An Open Clinical Pilot Study to Evaluate the Safety and Efficacy of Natto Kinaseas an Add-on Oral Fibrinolytic Agent Tolow Molecular Weight Heparin & Anti-Plateletsin Acute Ischeamic Stroke" re NDI 631, Nattolife/Nattokinase Enzyme from Zytech Biotech PVT LTD Supporting & Related Material Background Material 2014-02-28T05:00:00Z 2014 2     2016-08-15T20:52:33Z   0 0 0900006480c36026

Links from other tables